Clinical Trial Update: Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating targeted anticoagulation to reduce inflammation and cellular activation in long-term HIV disease has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulation Disorders
• HIV Infection
• Inflammation

Snippet

Sponsor: Hennepin Healthcare Research Institute | Conditions: Inflammation, Coagulation | Phase 2 | Status: COMPLETED | Results posted: 2019-09-06